Journal article
Ex Vivo Response to Histone Deacetylase (HDAC) Inhibitors of the HIV Long Terminal Repeat (LTR) Derived from HIV-Infected Patients on Antiretroviral Therapy
Hao K Lu, Lachlan R Gray, Fiona Wightman, Paula Ellenberg, Gabriela Khoury, Wan-Jung Cheng, Talia M Mota, Steve Wesselingh, Paul R Gorry, Paul U Cameron, Melissa J Churchill, Sharon R Lewin
PLoS ONE | PUBLIC LIBRARY SCIENCE | Published : 2014
Grants
Awarded by Australian National Health and Medical Research Council (NHMRC)
Awarded by National Institutes of Health, USA
Awarded by Division of AIDS, National Institute of Allergy and Infectious Disease, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE)
Awarded by NHMRC Early Career Fellowship
Awarded by NHMRC Dora Lush biomedical post-graduate scholarship
Funding Acknowledgements
This work was supported by an Australian National Health and Medical Research Council (NHMRC) project grant 1009533 and 1051093; the National Institutes of Health, USA (NIMH100594) and the Division of AIDS, National Institute of Allergy and Infectious Disease, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE; U19AI096109). S. R. L. is an NHMRC senior practitioner fellow. P. R. G is supported by an Australian Research Council Future Fellowship (FT2). L. R. G was supported by a NHMRC Early Career Fellowship (GNT0606967). G. K. is a recipient of an NHMRC Dora Lush biomedical post-graduate scholarship (579719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.